Skip to main content
SpringerLink
Log in

Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Coffin J: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267: 483–489.

    PubMed  CAS  Google Scholar 

  2. Van Gemen B, Van Beuningen R, Nabbe A, Van Strijp D, Jurriaans S, Lens P, Kievits T: A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent labelled probes. Journal of Virological Methods 1994, 49: 157–167.

    Article  PubMed  Google Scholar 

  3. Soriano V, Gómez-Cano M, Adrados M, Castilla J, Villalba N, Laguna F, González-Lahoz J: Short-term response to indinavir in patients with advanced HIV disease with prior heavy exposure to nucleoside analogues. AIDS 1997, 11: 391–392.

    PubMed  CAS  Google Scholar 

  4. O'Brien W, Hartigan R Martin D, Esinhart J, Hill A, Benoit S: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New England Journal of Medicine 1996, 334: 426–431.

    Article  PubMed  Google Scholar 

  5. Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L: Response of HIV RNA to didanosine as a predictive marker of survival. AIDS 1995, 9: 159–163.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Instituto de Salud Carlos III, Sinesio Delgado 10, 28029, Madrid, Spain

    V. Soriano, Ma Gömez-Cano, F. Laguna & J. González-Lahoz

  2. National Center for Epidemiology, Instituto de Salud Carlos III, Sinesio Delgado 10, 28029, Madrid, Spain

    J. Castilla

Authors
  1. V. Soriano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ma Gömez-Cano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Castilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Laguna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. González-Lahoz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soriano, V., Gömez-Cano, M., Castilla, J. et al. Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy. Eur. J. Clin. Microbiol. Infect. Dis. 16, 477–479 (1997). https://doi.org/10.1007/BF02471918

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02471918

Keywords

Search

Navigation